96 related articles for article (PubMed ID: 8360810)
1. Differential binding of acapsulate and encapsulated strains of Cryptococcus neoformans to human neutrophils.
Richardson MD; White LJ; McKay IC; Shankland GS
J Med Vet Mycol; 1993; 31(3):189-99. PubMed ID: 8360810
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
Levitz SM; DiBenedetto DJ
J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
[TBL] [Abstract][Full Text] [Related]
3. Activated neutrophils exhibit enhanced phagocytosis of Cryptococcus neoformans opsonized with normal human serum.
Kozel TR; Pfrommer GS; Redelman D
Clin Exp Immunol; 1987 Oct; 70(1):238-46. PubMed ID: 2961491
[TBL] [Abstract][Full Text] [Related]
4. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils.
Kozel TR; Highison B; Stratton CJ
Infect Immun; 1984 Feb; 43(2):574-9. PubMed ID: 6363293
[TBL] [Abstract][Full Text] [Related]
5. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin.
Levitz SM; Tabuni A
J Clin Invest; 1991 Feb; 87(2):528-35. PubMed ID: 1991837
[TBL] [Abstract][Full Text] [Related]
6. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages.
Bolaños B; Mitchell TG
J Med Vet Mycol; 1989; 27(4):203-17. PubMed ID: 2677298
[TBL] [Abstract][Full Text] [Related]
7. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils.
Monari C; Retini C; Casadevall A; Netski D; Bistoni F; Kozel TR; Vecchiarelli A
Eur J Immunol; 2003 Apr; 33(4):1041-51. PubMed ID: 12672070
[TBL] [Abstract][Full Text] [Related]
8. Opsonization and phagocytosis of Cryptococcus neoformans.
Kozel TR
Arch Med Res; 1993; 24(3):211-8. PubMed ID: 8298269
[TBL] [Abstract][Full Text] [Related]
9. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
[TBL] [Abstract][Full Text] [Related]
10. [The defensive role of human pulmonary alveolar macrophages and polymorphonuclear leukocytes against a strongly or weakly virulent strains of Cryptococcus neoformans].
Tabeta H; Kohno N; Kamei K; Honda A; Unno H; Nagao K; Yamaguchi T; Miyaji M
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Sep; 29(9):1174-9. PubMed ID: 1753544
[TBL] [Abstract][Full Text] [Related]
11. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans.
Cross CE; Collins HL; Bancroft GJ
Immunology; 1997 Jun; 91(2):289-96. PubMed ID: 9227330
[TBL] [Abstract][Full Text] [Related]
12. Role of hyaluronidase in in vitro phagocytosis of encapsulated yeasts of Cryptococcus neoformans.
Mathai A; Radhakrishnan VV
Indian J Exp Biol; 1983 May; 21(5):285-8. PubMed ID: 6365748
[No Abstract] [Full Text] [Related]
13. Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans.
Lovchik JA; Lipscomb MF
Am J Respir Cell Mol Biol; 1993 Dec; 9(6):617-27. PubMed ID: 8257594
[TBL] [Abstract][Full Text] [Related]
14. Role of the capsule in phagocytosis of Cryptococcus neoformans.
Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
Rev Infect Dis; 1988; 10 Suppl 2():S436-9. PubMed ID: 3055212
[TBL] [Abstract][Full Text] [Related]
15. Comparisons between in vitro glial cell adherence and internalization of non-encapsulated and encapsulated strains of Cryptococcus neoformans.
Merkel GJ; Scofield BA
J Med Vet Mycol; 1994; 32(5):361-72. PubMed ID: 7531242
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions.
Zaragoza O; Taborda CP; Casadevall A
Eur J Immunol; 2003 Jul; 33(7):1957-67. PubMed ID: 12884862
[TBL] [Abstract][Full Text] [Related]
17. Binding of cryptococcal polysaccharide to Cryptococcus neoformans.
Kozel TR; Hermerath CA
Infect Immun; 1984 Mar; 43(3):879-86. PubMed ID: 6365785
[TBL] [Abstract][Full Text] [Related]
18. Biotinylation and characterization of Cryptococcus neoformans cell surface proteins.
Foster AJ; Bird RA; Smith SN
J Appl Microbiol; 2007 Aug; 103(2):390-9. PubMed ID: 17650199
[TBL] [Abstract][Full Text] [Related]
19. Activation of the complement system by the capsule of Cryptococcus neoformans.
Kozel TR
Curr Top Med Mycol; 1993; 5():1-26. PubMed ID: 8242797
[TBL] [Abstract][Full Text] [Related]
20. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.
Kozel TR; Follette JL
Infect Immun; 1981 Mar; 31(3):978-84. PubMed ID: 7014468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
